Funding to Advance Pipeline of Anti-fibrotic Molecules into the Clinic

16-Jun-2021

Alentis Therapeutics, the Swiss biotech developing breakthrough treatments for fibrotic diseases, announced that it has raisedUSD67 (CHF60) millionin a Series B financing round. The funding will be used primarily for proof-of-concept clinical trials of Alentis’ first in class, Claudin-1 ...

more

Seed financing round for female-founded circular bioeconomy startup traceless materials

11-May-2021

The funding lays the foundation to bring an advanced natural material to market that solves the global plastic pollution. The Hamburg-based, female-founded startup traceless materials has developed a holistically sustainable alternative for plastics and bioplastics that is fully compostable in ...

more

Biotech startup to advance personalized medicine for cancer patients

28-Apr-2021

PreComb Therapeutics announced the successful completion of the seed financing round led by Kinled Austria, the High-Tech Gründerfonds and FiveT capital, in addition to participations from other investors.Patrick Aisher, managing partner at Kinled Austria, joined the company’s board of ...

more

Twenty-One Semiconductors successfully closes seed financing round with High-Tech Gründerfonds

20-Apr-2021

High-Tech Gründerfonds (HTGF) invests in the start-up Twenty-One Semiconductors (21S) as part of a first round of financing. The spin-off from the University of Stuttgart produces semiconductor-based laser crystals for biomedical applications. These crystals enable the realization of laser ...

more

Newly founded biotech company ActiTrexx receives funding of € 3.5 million

04-Mar-2021

ActiTrexx GmbH, a new biotech spin-off from the University Medical Center Mainz, Germany, has successfully closed its Series A financing. A consortium led by LBBW Venture Capital GmbH with participation from MediVentures GmbH, High-Tech Gründerfonds (HTGF) and Investitions- und Strukturbank ...

more

GeneQuine Biotherapeutics Secures more than €9 Million

28-Jan-2021

GeneQuine Biotherapeutics GmbH, a biotech company focused on the development of gene therapy for musculoskeletal disorders, announced that it has raised €5.4 million in Series A financing and €3.65 million non-dilutive funding bringing the total amount raised to €9.05 million. The Series A ...

more

i3 Membrane receives 7 figure sum for development and market launch

26-Jan-2021

Four investors are financing the further growth of i3 Membrane GmbH. High-tech venture capital investor HTGF from Bonn, Germany, and three private investors are together investing a 7 figure sum in the further development and market launch of new separation technology for biological molecules. ...

more

LignoPure secures € 2.2 Million seed round

20-Jan-2021

LignoPure invented a unique approach to replace plastics through utilization of wood waste and the team just closed its seed round with HTGF, IFH and Tanovis AG to scale its own technology for the transformation of lignin – a byproduct of the pulp and paper industries and biorefineries – into ...

more

Start-up announces $24 million Series A financing and appoints Jason T. Gammack as CEO

18-Dec-2020

Resolve Biosciences, the pioneer in Molecular Cartography™, announced the completion of a $24 million Series A financing round and the appointment of Co-founder Jason T. Gammack as Chief Executive Officer. The company’s Molecular Cartography platform is a groundbreaking multi-analyte and highly ...

more

International pool invests ~ 2 Mio € in medicine start-up mediaire

17-Dec-2020

HTGF, primeCROWD and LIFTT are part of an international round for the development of “Deep learning diagnostic” which allows faster, more accurate and safer MRI analysis. Expansion into European markets will start in 2021 accompanied by a significant expansion of product portfolio mediaire, the ...

more